FDA Drug Approvals
Printable Version   Email to a friend

Tramadol ER Biovail Corporation - Treatment for Chronic Pain

Tramadol ER is a once-daily formulation of tramadol hydrochloride approved for the treatment of moderate to moderately severe chronic pain. A trade name is yet to be finalized.

Related Articles:

Biovail Updates Status of NDA for Tramadol ER - March 30, 2005

Biovail's Ralivia ER Receives Approvable Letter From FDA - November 1, 2004

Biovail NDA For Ralivia ER -- Tramadol Extended Release Tablets -- Accepted for Review - February 26, 2004

Latest FDA Drug Approvals...

FDA Drug Approvals Archive

2008: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct
2007: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2006: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2005: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2004: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2003: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2002: Oct | Dec

More News Resources


MedNotes
Advertisement